Document published by the source itself
MM23 | Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms)
The molecular-reference standard for solid-tumor testing, addressed to lab directors, developers and regulators.
Source
CLSI MM23 is intended for molecular diagnostic laboratory directors, industry laboratory professionals, health care professionals (including anatomic and clinical pathologists), manufacturers and developers, and regulatory and accreditation organizations.
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Key takeaways
The molecular-reference standard for solid-tumor testing, addressed to lab directors, developers and regulators.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-09
2026-10-09
professional use
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.